Ginkgo Bioworks Holdings (DNA) Shares Outstanding (Weighted Average) (2019 - 2026)

Ginkgo Bioworks Holdings (DNA) has 8 years of Shares Outstanding (Weighted Average) data on file, last reported at $59.6 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 9.81% year-over-year to $59.6 million; the trailing twelve-month figure through Mar 2026 stood at $59.6 million (up 9.81% YoY), and the FY2025 full-year result was $55.5 million, up 6.87% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $59.6 million, up from $55.5 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $1.9 billion in Q2 2023 and bottomed at $1.6 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $54.2 million (2025), against an average of $452.8 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) tumbled 99.88%; it then surged 119026.78% in 2023.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $42.0 million in 2022, then grew by 15.8% to $48.6 million in 2023, then increased by 6.76% to $51.9 million in 2024, then increased by 6.87% to $55.5 million in 2025, then grew by 7.4% to $59.6 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $59.6 million (Q1 2026), $55.5 million (Q4 2025), and $54.9 million (Q3 2025), per Business Quant data.

Peer Comparison